Jingge Zhang
Overview
Explore the profile of Jingge Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang Y, Zhang J, Wang J, Yang Y, Tan X, Li S, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2500825.
PMID: 39965083
The efficacy of in situ cancer vaccines (ISCVs) is hindered by the poor immunogenicity of tumor cells. Here, PRIZE, a P53-repair nanosystem based on a virus-mimicking nanostructure to deliver p53...
2.
Mao C, Zhang J, Yang C, Mei L, Feng Y, Dai F, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Nov;
1871(1):167558.
PMID: 39488300
Background: Our objective was to elucidate the pivotal roles of BCAR1 in unfolded protein response (UPR), autophagy and vasculogenic mimicry (VM) formation, processes that essential for the metastasis of lung...
3.
Zhao L, Li S, Wang X, Zhang L, Zhang J, Liu X, et al.
J Inflamm Res
. 2024 Oct;
17:6935-6954.
PMID: 39372588
Background: Obesity is recognized as a primary risk factor for cerebral ischemia, which has shown a significant increase in its incidence among obese patients. The exact mechanism by which obesity...
4.
Yin M, Sun H, Li Y, Zhang J, Wang J, Liang Y, et al.
Small
. 2024 Jul;
20(43):e2402715.
PMID: 39004872
Messenger RNA (mRNA) is an emerging class of therapeutic agents for treating a wide range of diseases. However, due to the instability and low cell transfection rate of naked mRNA,...
5.
Li D, Ha E, Zhou Z, Zhang J, Zhu Y, Ai F, et al.
Adv Mater
. 2023 Dec;
36(13):e2308747.
PMID: 38108600
Multienzyme-mimicking redox nanozymes capable of efficient reactive oxygen species (ROS) generation and cellular homeostasis disruption are highly pursued for cancer therapy. However, it still faces challenges from the complicate tumor...
6.
Liang Y, Zhang J, Xu C, Wang J, Han W, Yang J, et al.
ACS Nano
. 2023 Jul;
17(15):15025-15043.
PMID: 37481734
CRISPR/Cas9 systems have great potential to achieve sophisticated gene therapy and cell engineering by editing multiple genomic loci. However, to achieve efficient multiplex gene editing, the delivery system needs adequate...
7.
Zhang J, Ha E, Li D, He S, Wang L, Kuang S, et al.
J Mater Chem B
. 2023 May;
11(19):4274-4286.
PMID: 37140154
Nanozymes mediated catalytic therapy can produce toxic reactive oxygen species (ROS) and destroy the metabolic balance of tumor cells, providing a new direction for cancer treatment. However, the catalytic efficiency...
8.
Liang Y, Wang J, Xu C, Han W, Wu S, Wu Y, et al.
Adv Sci (Weinh)
. 2023 Apr;
10(18):e2300127.
PMID: 37088730
Liver fibrosis is a progressive histological manifestation that happens in almost all chronic liver diseases. An unabated liver fibrosis may eventually develop into liver cirrhosis or hepatocellular carcinoma. Yet, the...
9.
Li D, Ha E, Zhang J, Wang L, Hu J
Nanoscale
. 2022 Sep;
14(39):14471-14481.
PMID: 36156057
Near-infrared light-induced catalysts are considered to be potential nanoagents for tumor therapy. Cerium (Ce) is a non-biotoxic lanthanide element and exhibits variable valence states for catalytic reactions. In this work,...
10.
Zhang J, Ha E, Li D, Wang L, Hu J
Nanoscale
. 2022 Jul;
14(30):10750-10760.
PMID: 35797993
Stimulus-responsive ternary chalcogenide nanomaterials are regarded as promising 'all-in-one' nanotheranostics agents on account of their tunable band structures and multi-metal intrinsic properties. Herein, ultrasmall AgBiSe nanodots are prepared by a...